Werewolf Therapeutics

Werewolf Therapeutics is a company listed under the stock ticker HOWL (US).

View the org chart displaying its 15 main executives

Most searched biographies at Werewolf Therapeutics

• Dan Hicklin, President, Chief Executive Officer and Director
• Briggs Morrison, Director
• Alon Lazarus, Director

Popular executive movements at Werewolf Therapeutics

• Michael Atkins has joined the company as Director  (posted on January 5 2024).

Create your alert
to follow the executive moves at Werewolf Therapeutics.

Werewolf Therapeutics has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Werewolf Therapeutics

• News & Events | Werewolf Therapeutics Inc.
• PRESS RELEASE: Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines - Werewolf Therapeutics

Social media about Werewolf Therapeutics

• Werewolf Therapeutics on Wikipedia, Google News & Yahoo Finance
• Werewolf Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Dan Hicklin

Call Werewolf Therapeutics at +1 301...

View the org chart

Register to receive your alert

Report an error